From the Departments of ∗Clinical Epidemiology
†English, Faculty of Medicine, Hyogo College of Medicine, Nishinomiya, Japan
‡Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital and Harvard Medical School
§Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts.
Correspondence: Takeshi Morimoto, MD, PhD, MPH, Department of Clinical Epidemiology, Hyogo College of Medicine, 1–1 Mukogawa, Nishinomiya, Hyogo 663–8501, Japan (e-mail: [email protected]).
There were no conflicts of interest other than those described in the following: Dr Bates is a coinventor on Patent No. 6029138 held by Brigham and Women's Hospital on the use of decision support software for medical management, licensed to the Medicalis Corporation. He holds a minority equity position in the privately held company Medicalis, which develops Web-based decision support for radiology test ordering. He serves on the board for SEA Medical Systems, which makes intravenous pump technology. He is on the clinical advisory board for Zynx, Inc, which develops evidence-based algorithms, and Patient Safety Systems, which provides a set of approaches to help hospitals improve safety. He consults for EarlySense, which makes patient safety monitoring systems. He receives equity and cash compensation from QPID, Inc, a company focused on intelligence systems for electronic health records. Dr Bates' financial interests have been reviewed by Brigham and Women's Hospital and Partners HealthCare in accordance with their institutional policies.
This study was supported by grants of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (17689022, 22390103, 22790494, 24689027, 25860484, and 26293159), the Pfizer Health Research Foundation, and the Uehara Memorial Foundation.